Literature DB >> 3428666

Bradykinin in carcinoid syndrome.

J Gustafsen1, S Boesby, F Nielsen, J Giese.   

Abstract

Bradykinin concentrations in peripheral venous blood were measured in seven patients with carcinoid syndrome. The diagnosis was based on typical symptoms and raised urinary excretion of 5-hydroxy-3-indole acetic acid; the carcinoid tumour was verified histologically. Two patients were flushing constantly and the other patients had flushing attacks two to 10 times daily. Several blood samples were taken at weekly intervals from six of seven patients. During 30 sampling procedures the patients were flushing during sampling in 12 instances. Bradykinin was measured by a sensitive solid phase radioimmunoassay technique. Blood bradykinin concentration was normal in all patients. Bradykinin is unlikely to be the vasoactive mediator of flushing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428666      PMCID: PMC1433706          DOI: 10.1136/gut.28.11.1417

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  PATHOGENETIC STUDIES OF EXPERIMENTALLY INDUCED HEART LESIONS AND THEIR RELATION TO THE CARCINOID SYNDROME.

Authors:  M SPATZ
Journal:  Lab Invest       Date:  1964-03       Impact factor: 5.662

2.  The bronchoconstrictor action of bradykinin in the guinea-pig.

Authors:  H O COLLIER; J A HOLGATE; M SCHACHTER; P G SHORLEY
Journal:  Br J Pharmacol Chemother       Date:  1960-06

3.  Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxy-tryptamine in blood and urine.

Authors:  B PERNOW; H SILWER; J WALDENSTROM
Journal:  Acta Med Scand       Date:  1956-12-08

4.  The mechanism of facial flushes in the carcinoid syndrome.

Authors:  J I ROBERTSON; W S PEART; T M ANDREWS
Journal:  Q J Med       Date:  1962-01

Review 5.  Pharmacologic and endocrine aspects of carcinoid syndrome.

Authors:  J A Oates; T C Butler
Journal:  Adv Pharmacol       Date:  1967

6.  Prostaglandins in amine-peptide-secreting tumours.

Authors:  M Sandler; S M Karim; E D Williams
Journal:  Lancet       Date:  1968-11-16       Impact factor: 79.321

Review 7.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

8.  Evidence for the release of bradykinin in carcinoid syndrome.

Authors:  J A Oates; W A Pettinger; R B Doctor
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

9.  Antisera raised against eledoisin and kassinin detect elevated levels of immunoreactive material in plasma and tumor tissues from patients with carcinoid tumors.

Authors:  I Norheim; E Theodorsson-Norheim; E Brodin; K Oberg; G Lundqvist; S Rosell
Journal:  Regul Pept       Date:  1984-11

10.  An improved method for the determination of human blood kinin levels by sensitive kinin radioimmunoassay.

Authors:  K Shimamoto; T Ando; S Tanaka; Y Nakahashi; T Nishitani; S Hosoda; H Ishida; O Iimura
Journal:  Endocrinol Jpn       Date:  1982-08
View more
  3 in total

1.  Histamine in carcinoid syndrome.

Authors:  J Gustafsen; S Boesby; W K Man
Journal:  Agents Actions       Date:  1988-08

2.  Epidural anaesthesia for transurethral resection of the prostate in a patient with carcinoid syndrome.

Authors:  K Monteith; O P Roaseg
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

Review 3.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.